【Diamond Biofund】March 2026 Revenue -NT$0.085 Billion (YoY +86.9%)
NQ Score
20/100
N1 Content Completeness
2
AI Summary (NQ-processed)
Diamond Biofund (6901), which invests in the biotech sector, reported a negative monthly revenue of -NT$0.085 billion for March 2026. However, this represents an +86.9% improvement year-over-year, meaning the loss was significantly reduced.